Purpose: Pituicytomas and spindle cell oncocytomas (SCOs) are extremely rare neoplasms of the sellar and suprasellar region that can often mimic pituitary adenomas. To date, there are relatively few cases of pituicytomas and SCOs reported; and most of these are small case series.
Methods: In this paper, we provide a retrospective review of the treatment, imaging characteristics, post-operative course, and histopathology of five cases of pituicytomas and two SCOs treated at the University of California, San Francisco (UCSF) over a 10-year period from 2003 to 2013.
Results: We find that pituicytomas and SCOs present similarly to pituitary adenomas, and look identical on CT or MR imaging. We histopathologically confirmed all pituicytomas with a combination of hematoxylin and eosin morphology and immunohistochemical positivity for vimentin and S100; SCOs stain for anti-mitochondrial antigen and endothelial membrane antigen. We observe positive thyroid transcription factor 1 (TTF1) immunohistochemistry in both cases of SCO, as well as in both of the cases of pituicytoma in which TTF1 staining was available.
Conclusions: This represents the largest single-institution case series of pituicytomas and SCOs to date, and also includes the first description of the management of a pregnant female with SCO. Our findings are consistent with the idea of common histogenesis for pituicytomas and SCOs, and also raise the possibility of more aggressive growth in SCOs as compared to pituicytomas.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11102-014-0568-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Recommendation to improve the WHO classification of posterior pituitary tumors as a unique entity: evidence from a large case series.
Endocr Connect
June 2022
Department of Neurosurgery, Huashan Hospital, Shanghai Medical School, Fudan University, Shanghai, China.
Article Synopsis
- Most studies on posterior pituitary tumors (PPTs) are limited to small case series or individual cases, leading to a need for more comprehensive research.
- A study of 51 patients revealed common symptoms like visual defects, headaches, and hypopituitarism, with unique radiological features suggesting a specific tumor type, while a majority underwent successful surgical removal.
- The results indicated that certain tumor types, particularly spindle cell oncocytomas, showed higher recurrence risks and proliferative activity, reinforcing the importance of including PPTs in the diagnosis of sellar and suprasellar masses.
Genetic and epigenetic characterization of posterior pituitary tumors.
Acta Neuropathol
December 2021
Department of Pathology, Neuropathology, University of Virginia Health System, Charlottesville, Virginia, USA.
Article Synopsis
- Pituicytoma, granular cell tumor, and spindle cell oncocytoma are rare tumors of the posterior pituitary that may share histological features, suggesting they could be part of a single entity.
- The study involved 47 tumor samples and found two main epigenomic subgroups based on DNA methylation, with one group exhibiting mutations in pathways linked to tumor growth.
- Analysis of clinical outcomes revealed that chromosomal imbalances correlate with worse progression-free survival, leading to a proposal for subclassifying these tumors into three distinct subtypes based on histology and genetic mutation patterns.
Posterior pituitary tumours: patient outcomes and determinants of disease recurrence or persistence.
Endocr Connect
April 2021
Department of Endocrinology, Postgraduate Institute of Medical Education and Research, (PGIMER), Chandigarh, India.
Objective: Posterior pituitary tumours (PPTs) are rare neoplasms with the four recognised subtypes unified by thyroid transcription factor -1 (TTF-1) expression, according to the 2017 WHO classification. Though traditionally defined as low-grade neoplasms, a substantial proportion of them show recurrence/persistence following surgery.
Methods: We selected patients with PPTs in our cohort of 1760 patients operated for pituitary tumours over the past 10 years (2010-2019).
Clinical-Pathological, Immunohistochemical, and Genetic Characterization of a Series of Posterior Pituitary Tumors.
J Neuropathol Exp Neurol
January 2021
ARC-Net Research Centre, University and Hospital Trust of Verona, Verona (AS), Italy.
Posterior pituitary tumors are supposed to represent the morphological spectrum of a single entity. Herein, we report the clinical-pathological, immunohistochemical, and genetic features of 5 spindle cell oncocytomas (SCOs), 3 pituicytomas, and 1 granular cell tumor (GCT). SCOs had the highest local invasiveness and affected older subjects.
View Article and Find Full Text PDFEvaluation of expression of somatostatin receptor 1, 2, 3, 5 and dopamine D2 receptor in spindle cell oncocytomas of posterior pituitary.
Pituitary
February 2019
4th Department of Internal Medicine, University Hospital and Faculty of Medicine Hradec Kralove, Charles University, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Purpose: Spindle cell oncocytomas (SCOs) are very rare tumors of the posterior pituitary with potential for locally aggressive behaviour. Their treatment includes surgery and possibly radiotherapy, however other options are lacking. Somatostatin receptors (SSTs) are a possible therapeutic target for somatostatin analogues and their expression has been demonstrated recently in closely related pituicytomas, but there are no data about their presence in SCOs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!